Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Continuous glucose monitoring (CGM) is a great tool that improves clinical outcomes for people with diabetes; these individuals are often happy to get this new technology.
However, there can be some initial barriers that both people with diabetes and clinicians need to overcome.
BARRIER 1: Wearing something on the body so other people know the person has diabetes.
SOLUTION 1: Let the person see the size of different devices through demonstrations and show possible discreet places on the body where they can be worn.
BARRIER 2: Cost of the CGM.
SOLUTION 2: Find out insurance requirements to see if the CGM can be covered and what is required for coverage.
BARRIER 3: Too much information from CGM can be overwhelming for the individual.
SOLUTION 3: Make sure alarms and alerts are set appropriately to avoid alarm fatigue—have the alerts go off when it matters most, like during hypoglycemia. Look at the device at key times only, like before meals, before bedtime, and before activities like exercising and driving, and utilize CGM to determine glycemic trends.
BARRIER 4: Clinicians are hesitant to embrace CGM technology.
SOLUTION 4: There are various resources available to help clinicians understand CGM technology and to assist in integrating CGM into their practice settings.
Clinical Pharmacy Specialist/CGM Program Coordinator
Department of Endocrinology, Diabetes, and Metabolism
Cleveland Clinic Diabetes Center
Certified Diabetes Educator and Clinical Dietitian
Mountain Vista Medicine
South Jordan, Utah
Associate Director, Scientific Services
This activity is intended for diabetes specialists, primary care clinicians, and other healthcare providers who are part of the diabetes care team including nurses, diabetes care and education specialists, pharmacists, and registered dietitians.
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Endocrine Society has achieved Accreditation with Commendation.The Endocrine Society designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Association of Diabetes Care & Education Specialists is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This program provides 0.25 contact hour of continuing education credit.
Provider approved by the California Board of Registered Nursing, Provider # 10977, for 0.25 Contact Hour. RNs must retain this document for 4 years after the activity concludes.
The Association of Diabetes Care & Education Specialists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 0.25 contact hours (0.025 CEU's) of continuing education credit.
ACPE Universal Activity Number: 0069-9999-20-041-H01-P
Effective date: March 31, 2020 to March 31, 2021
This program has been made available online.
Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 31, 2020, through March 30, 2021:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
Concise CCO expert commentary on potential side effects with GLP-1 receptor agonists in patients with type 2 diabetes
Neil Skolnik, MD reviews GLP-1 RAs to address elevated A1C, obesity, and CV risk, plus strategies to improve tolerability, adherence
Hyperglycemia can be a deadly complication for anyone with diabetes, but there are tools that can reduce this risk including GLP-1 medications. Learn more today.
CME commentary: GLP-1 receptor agonists to prevent major cardiovascular adverse events (MACE) in type 2 diabetes (T2D), cardiovascular disease (CVD)